Skip to main content

MoneyWorks4Me

Strides Pharma Science informs about press release

19 Mar 2021 Evaluate

Strides Pharma Science has informed that it has attached Press Release on 19th March 2021 issued by Stelis Biopharma, the biopharmaceutical division of Strides titled ‘Stelis concludes US$ 195m Series B and Series C fund raise Significant interest from marquee long term investors’.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..